Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Concurrent Quantification of Tryptophan and Its Major Metabolites.
Diagnostic ability of a new method for measuring haemoglobin levels in the optic nerve head in multiple sclerosis patients.
Human Mesenchymal Stem Cells Upregulate CD1dCD5(+) Regulatory B Cells in Experimental Autoimmune Encephalomyelitis.
Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation.
Prediction of risk of fracture in the tibia due to altered bone mineral density distribution resulting from disuse: A finite element study.
Automated Determination of Brain Parenchymal Fraction in Multiple Sclerosis.
Optic neuritis in a psoriatic arthritis patient treated by infliximab.
Platelets and neurovascular inflammation.
Month of birth and risk of multiple sclerosis in a Portuguese population.
Mystery Case: Balo concentric sclerosis.
Transverse myelitis in Behçet's disease: a series of 4 cases and review of the literature.
Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.
The clinical impact of cerebellar grey matter pathology in multiple sclerosis.
Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
Transvascular autonomic modulation: a modified balloon angioplasty technique for the treatment of autonomic dysfunction in multiple sclerosis patients.
Macrophages derived from infiltrating monocytes mediate autoimmune myelin destruction.
Neurosarcoidosis as an MS Mimic: The trials and tribulations of making a diagnosis.
Neuromyelitis Optica Spectrum Disorder Associated with Cervical Spondylosis.
miR-29ab1 Deficiency Identifies a Negative Feedback Loop Controlling Th1 Bias That Is Dysregulated in Multiple Sclerosis.
Foot placement patterns of female rollator users with multiple sclerosis in the community.
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.
FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease.
Parkinsonism in multiple sclerosis patients: A casual or causal association?
Longitudinal interferon-β effects in multiple sclerosis: Differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13.
Analysis of "task-positive" and "task-negative" functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis.

Pages